Chang X#, Liang H#, Xiao J#, Yang D, Yu J, Shan J, Dong X, Deng W, Zhao Y, Jiang L, Long L, Teng Y, Yu H, Yu R, Ma S*, Shi A*.Definitive radiotherapy provides comparable survival with lower toxicity compared with concurrent chemoradiotherapy after long-course induction chemoimmunotherapy in unresectable non-small-cell lung cancer.,Ther Adv Med Oncol.,18:17588359261447969.

Jiayi Yu, Jingwei Zhang, Xiao Chang, Dan Yang, Jiahui Shan, Leilei Jiang, Liuhua Long, Yue Teng, Xin Dong, Rong Yu, Huiming Yu, Jun Zhao* , Shaohua Ma* , Anhui Shi*. Real-world Clinical Outcomes in Patients with Limited Stage SCLC Who Received High-dose Hyperfractionated Simultaneous Integrated Boost Radiotherapy versus Standard-dose radiotherapy.,Pract Radiat Oncol.,

Hu J, Yang L, Kang N, Wang N, Shen L, Zhang X, Liu S, Li H, Xue T, Ma S*, Zhu T*. Associations between long-term exposure to fine particulate matter and its constituents with lung cancer incidence: Evidence from a prospective cohort study in Beijing, China.,Environ Pollut,368:125686.

Jiadong Zhou, Xiao Albert Zhou, Li Hu, Yujie Ma, Jun Zhan, Zhanzhan Xu, Mei Zhou, Qinjian Shen, Zhaofei Liu, Shaohua Ma*, Yuntao Xie*, Jiadong Wang*. Replication stress inducing ELF3 upregulation promotes BRCA1-deficient breast tumorigenesis in luminal progenitors.,Elife,12:RP89573.

Yifan Chen, Guangliang Qiang, Liang Jin, Yan Sun, Guozhou Zhang, Fengling Hu, Jinhui Feng, Feng Wei, Shengxin Zeng, Lixiang Xue, Huihui Zeng, Shaohua Ma. The novel thioredoxin reductase inhibitor butaselen suppresses lung cancer by inducing oxidative stress.,Redox Rep.,30(1):2588086.

Luyan Shen, Jingtao Liu, Fengling Hu, Yifan Fang, Yaya Wu, Wei Zhao, Shaohua Ma. Single-cell RNA sequencing reveals aberrant sphingolipid metabolism in non-small cell lung cancer impacts tumor-associated macrophages and stimulates angiogenesis via macrophage inhibitory factor signaling.,Thoracic Cancer,15(14):1164-1175.

Houqing Yin, Zequn Wang, Dan Wang, Muhadaisi Nuer, Mengyuan Han, Peng Ren, Shanwu Ma, Chutong Lin, Jingjing Chen, Haocheng Xian, Dongmei Ai, Xuejun Li, Shaohua Ma*, Zhiqiang Lin*, Yan Pan*. TIMELESS promotes the proliferation and migration of lung adenocarcinoma cells by activating EGFR through AMPK and SPHK1 regulation.,Eur J Pharmacol.,955:175883

Zhiqiang W, Shaohua M.Perioperative outcomes of robotic-assisted versus video-assisted thoracoscopic lobectomy: A propensity score matched analysis.,Thoracic Cancer,

Yifan Chen , Shanwu Ma , Chutong Lin , Zhipeng Zhu, Jie Bai, Zhongnan Yin, Yan Sun, Fengbiao Mao, Lixiang Xue*, Shaohua Ma*. Integrative analysis of DNA methylomes reveals novel cell-free biomarkers in lung adenocarcinoma.,Front Genet.,14:1175784.

Fengling Hu, Chutong Lin, Hongling Chu, Peng Ren, JingdiWang, Shaohua Ma.Prognostic value of different N1 lymph node zones in pN1M0 non-small cell lung cancer: a systematic review and meta-analysis.,Sci Rep.,11(1):21606.

Ting Wang, Ning Zhang, Shipan Fan, Lianzheng Zhao, Wanlu Song, Yuhuan Gong, Quan Shen, Cheng Zhang, Peng Ren, Chutong Lin, Wei Fu, George F Gao, Shaohua Ma*, Yuhai Bi*, Ye-Guang Chen*.Establishment of human distal lung organoids for SARS-CoV-2 infection.,Cell Discov.,7(1):108.

Li J, Ma S. History and current situation of neoadjuvant treatment for locally advanced esophageal cancer.,Thoracic Cancer,12(17):2293-2299.

Jieda Cui, Peng Ren, Yan Li, Yunfan Ma, Jingdi Wang, Chutong Lin, Liang Jing, Xuexia Tong, Shaohua Ma, Juan Chen.ESRP1 as a prognostic factor of non-small-cell lung cancer is related to the EMT transcription factor of Twist.,Thoracic Cancer,12(18):2449-2457.

Jiahui Shan#, Jiayi Yu#, Lujun Zhao#, Dan Yang, Xiao Chang, Leilei Jiang, Liuhua Long, Yue Teng, Xin Dong, Rong Yu, Huiming Yu, Shaohua Ma *, Anhui Shi*. Impact of chemotherapy dose reduction during concurrent chemoradiotherapy on survival outcomes in limited-stage small-cell lung cancer.,BMC Cancer.,

Fu H, Shen L, Huang B, Ma S.Clinical strategies for perioperative management of esophageal squamous cell carcinoma in the immunotherapy era,Beijing Da Xue Xue Bao Yi Xue Ban.,58(2):266-271.

精准医学, 参编, 北京大学医学出版社, 2025.8

北京市卫生健康先进个人, 北京市卫生健康先进个人, 第1完成人, 北京市卫生健康委员会, 2025.12

中央保健工作先进个人, 中央保健工作先进个人, 第1完成人, 人力资源社会保障部、中央保健委员会办公室, 2025.12

MIF/CD74-PPARγ-ASAH1轴调控鞘脂代谢促进巨噬细胞M 2c极化诱导非小细胞肺癌免疫治疗抵抗的机制研究, 课题负责人, 2026.1.1～2029.12.31, 国家自然科学基金面上项目

以临床研究驱动胸部肿瘤综合诊疗新范式的建立及关键节点技术突破, 课题负责人, 2024.11.1～2027.10.31, 北京市卫健委研究型病房卓越临床研究计划

微肿瘤模型用于精准预测非小细胞肺癌新辅助化免治疗应答及机制探索的研究, 课题负责人, 2024.10.1～2027.9.30, 北京市自然科学基金-昌平创新联合基金重点研究专项

基于MRD的非小细胞肺癌术后适应性治疗研究, 课题负责人, 2025.1.1～2027.12.31, 北京市医管中心“扬帆”计划诊疗能力提升项目

阿得贝利单抗联合化疗用于局部晚期可切除食管鳞癌围术期治疗的单臂、开放、单中心探索性研究, 课题负责人, 2024.11.1～2027.10.31, 国家卫健委“创新药物上市后临床研究科研专项”

联合VOCs检测与影像组学双模态肺癌诊筛一体化研究, 课题负责人, 2024.8.1～2027.8.31, 中央保健委员会科研课题

非小细胞肺癌中生物节律基因Timeless破坏鞘脂代谢稳态的作用机制和功能特征, 课题负责人, 2024.1.1～2026.12.31, 北京市自然基金面上项目

面向重大疾病的人工智能多模医学信息融合辅助诊疗决策系统研发和应用推广-肺癌部分, 课题负责人, 2023.10.1～2026.12.31, 国家发改委生物技术与信息技术融合应用工程项目

探索符合内蒙古地域特点的局部进展期非小细胞肺癌多学科诊疗模式, 课题负责人, 2023.11.1～2025.12.31, 内蒙古横向课题